{
    "SPADE_UN_13552": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_13552",
            "Peptide Name": "FBP",
            "Source": "Synthetic construct",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "RGAHIKGRWKSRCHRF",
            "Sequence Length": 16,
            "UniProt Entry": "No entry found",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Antimicrobial",
                "Antiviral(SARS-CoV-2)"
            ],
            "Target Organism": "[Ref.35259078]Virus:A(H1N1)(IC50 = 3.9 μg/ml);A(H3N2)(IC50 = 1.6 μg/ml);FluB (IC50 = 7.1 μg/ml);SARS-CoV-2 (HKU001a):inhibition of infection in Vero-E6 cells(IC50=2.9 μg/ml);SARS-CoV-2 (B.1.1.63, D614G):inhibition of infection in Vero-E6 cells(IC50=3.0 μg/ml);SARS-CoV-2(Delta):inhibition of infection in Vera-E6 cells(IC50=3.9 μg/ml).",
            "Hemolytic Activity": "[Ref.35259078]No significant hemolysis against Turkey red blood cells (RBC).",
            "Cytotoxicity": "[Ref.35259078]No significant cytotoxicity was detected in MDCK(Madin Darby canine kidney) cells at 1 mg/ml(TC50 > 1 mg/ml).",
            "Binding Target": "liposomes",
            "Linear/Cyclic": "Linear",
            "N-terminal Modification": "Free",
            "C-terminal Modification": "Free",
            "Stereochemistry": "L",
            "Structure Description": "Not found",
            "Formula": "C87H139N35O18S",
            "Mass": 1995.32,
            "PI": 12.0,
            "Net Charge": 8,
            "Hydrophobicity": -1.44,
            "Half Life": "Mammalian:1 hourYeast:2 minE.coli:2 min",
            "Comments": "The fusion-inhibition peptide FBP could broadly inhibit influenza virus and SARS-CoV-2 by interfering the viral fusion by the endocytic pathway and showed potently antiviral activity against the influenza virus in mice and SARS-CoV-2 variants in hamsters.",
            "Literature": [
                {
                    "Title": "Fusion-inhibition peptide broadly inhibits influenza virus and SARS-CoV-2, including Delta and Omicron variants.",
                    "Pubmed ID": "35259078",
                    "Reference": "Emerg Microbes Infect. 2022 Dec;11(1)926-937.",
                    "Author": "Zhao H, Meng X, Peng Z, Lam H, Zhang C, Zhou X, Chan JF, Kao RYT, To KK, Yuen KY.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=35259078"
                }
            ],
            "Frequent Amino Acids": "RGH",
            "Absent Amino Acids": "DELMNOPQTUVY",
            "Basic Residues": 8,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 4,
            "Polar Residues": 11,
            "Positive Residues": 8,
            "Negative Residues": 0,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_13811",
                    "Similarity": 0.9375,
                    "Sequence": "RGAHIKGRWDSRCHRF"
                },
                {
                    "SPADE_ID": "SPADE_UN_13810",
                    "Similarity": 0.875,
                    "Sequence": "RGAHINGRWDSRCHRF"
                },
                {
                    "SPADE_ID": "SPADE_N_14831",
                    "Similarity": 0.75,
                    "Sequence": "IPLRGAFINGRWDSQCHRFSNGAIACA"
                }
            ]
        }
    }
}